TrialPanorama/TrialPanorama-database huggingface dataset:
Study 37265425 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 37265868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37265937 — Surrogate Endpoint (SUR): Blood pressure
Study 37266942 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37266942 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37266982 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 37267439 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 37267439 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 37267439 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study 37267439 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 37267732 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 37267732 — Safety Biomarker (SAF): BDNF
Study 37267804 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 37268435 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 37268519 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 37268519 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37268640 — Surrogate Endpoint (SUR): Blood pressure
Study 37268640 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 37268907 — Surrogate Endpoint (SUR): Blood pressure
Study 37269192 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37269282 — Surrogate Endpoint (SUR): Blood pressure
Study 37269344 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 37269344 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 37269841 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 37269870 — Predictive Biomarker (PRD): TREM1 mRNA
Genes: TREM1
Study 37269904 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 37269904 — Predictive Biomarker (PRD): Microsatellite instability
Study 37269904 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 37269941 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 37270698 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 37271721 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 37272512 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 37272513 — Surrogate Endpoint (SUR): Pathological complete response
Study 37272516 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 37272516 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 37272521 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 37272521 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 37272521 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 37272527 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 37272535 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 37273420 — Predictive Biomarker (PRD): ANTXR1 mRNA
Genes: ANTXR1; ATR; TEM8
Study 37273420 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 37275884 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37275927 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 37275963 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37275963 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37275963 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 37275963 — Predictive Biomarker (PRD): Hormone receptor
Study 37276032 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 37276496 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 37276871 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37276913 — Surrogate Endpoint (SUR): Blood pressure
Study 37277217 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37277227 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 37277227 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 37277227 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 37277275 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 37277275 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 37277275 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study 37277275 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 37277877 — Predictive Biomarker (PRD): MMP2 mRNA
Genes: MMP2; CLG4A
Study 37277877 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37278302 — Monitoring Biomarker (MOI): HBV DNA
Study 37278621 — Surrogate Endpoint (SUR): Blood pressure
Study 37278638 — Predictive Biomarker (PRD): ENPP2 mRNA
Genes: ENPP2; ATX; PDNP2
Study 37278684 — Predictive Biomarker (PRD): INA mRNA
Genes: INA; NEF5
Study 37278879 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCNE1 mRNA
Genes: CCNE1; CCNE
Study 37278879 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 37278879 — Predictive Biomarker (PRD): MYCL mRNA
Genes: MYCL; BHLHE38; LMYC; MYCL1
Study 37278879 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study 37278968 — Predictive Biomarker (PRD): SLC35A2 mRNA
Genes: SLC35A2; UGALT; UGT; UGTL
Study 37278999 — Surrogate Endpoint (SUR): Blood pressure
Study 37279000 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 37279009 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37279009 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37279709 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 37279709 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study 37279709 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study 37279780 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37279797 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study 37279797 — Predictive Biomarker (PRD): Hormone receptor
Study 37279797 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37279855 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 37280029 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37280116 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37280238 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 37280238 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37280275 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study 37280275 — Predictive Biomarker (PRD): ICOSLG mRNA
Genes: ICOSLG; B7H2; B7RP1; ICOSL; KIAA0653
Study 37280275 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study 37280275 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 37280551 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 37280551 — Predictive Biomarker (PRD): Small-inducible cytokine A11
Genes: CCL11; SCYA11
Study 37280551 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study 37280551 — Predictive Biomarker (PRD): DNER mRNA
Genes: DNER; BET; UNQ262/PRO299
Study 37280551 — Predictive Biomarker (PRD): NRP1 mRNA
Genes: NRP1; NRP; VEGF165R
Study 37280551 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 37280551 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 37280688 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 37280688 — Safety Biomarker (SAF): RAS pathway
Study 37282666 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 37283627 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37283969 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37283977 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37284066 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 37285069 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37285133 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 37285195 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study 37285718 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37285718 — Predictive Biomarker (PRD): Hormone receptor
Study 37286048 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 37286303 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37286303 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 37286305 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37286305 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 37286305 — Predictive Biomarker (PRD): CD244 mRNA
Genes: CD244; 2B4
Study 37286305 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37286557 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37287037 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 37287037 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 37287037 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 37287037 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 37287037 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Platelet glycoprotein 4
Genes: CD36; GP3B; GP4
Study 37287037 — Predictive Biomarker (PRD): CR1 mRNA
Genes: CR1; C3BR
Study 37287037 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 37287037 — Predictive Biomarker (PRD): GCLM mRNA
Genes: GCLM; GLCLR
Study 37287037 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 37287037 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 37287037 — Predictive Biomarker (PRD): IFNGR1 mRNA
Genes: IFNGR1
Study 37287080 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 37287080 — Surrogate Endpoint (SUR): Bone mineral density
Study 37287870 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 37287970 — Predictive Biomarker (PRD): C-C motif chemokine 7
Genes: CCL7; MCP3; SCYA6; SCYA7
Study 37287970 — Predictive Biomarker (PRD): MMP12 mRNA
Genes: MMP12; HME
Study 37287970 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 37288292 — Surrogate Endpoint (SUR): Serum calcium
Study 37288570 — Surrogate Endpoint (SUR): Blood pressure
Study 37288582 — Surrogate Endpoint (SUR): Pathological complete response
Study 37288954 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37289256 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 37289263 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 37289448 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 37290104 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 37290104 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 37290104 — Surrogate Endpoint (SUR): Bone mineral density
Study 37290915 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 37290947 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 37290967 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 37291448 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study 37291448 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 37291651 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37291677 — Predictive Biomarker (PRD): TNFRSF1A mRNA
Genes: TNFRSF1A; TNFAR; TNFR1
Study 37291679 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37291731 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37291731 — Surrogate Endpoint (SUR): Blood pressure
Study 37292774 — Surrogate Endpoint (SUR): Blood pressure
Study 37293030 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 37294588 — Surrogate Endpoint (SUR): Blood pressure
Study 37294870 — Surrogate Endpoint (SUR): Forced vital capacity
Study 37294948 — Predictive Biomarker (PRD): VTCN1 mRNA
Genes: VTCN1; B7H4; UNQ659/PRO1291
Study 37295445 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 37295501 — Surrogate Endpoint (SUR): Blood pressure
Study 37295609 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 37295609 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37295816 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 37295816 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 37295816 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 37295816 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 37296463 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37296463 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 37296463 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37296922 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 37296922 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 37296922 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 37300573 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study 37300792 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37300792 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 37301631 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 37301768 — Surrogate Endpoint (SUR): Blood pressure
Study 37301885 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 37301934 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 37302393 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37302393 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 37302406 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37302449 — Predictive Biomarker (PRD): CYP1A1 mRNA
Genes: CYP1A1
Study 37302544 — Predictive Biomarker (PRD): SLC38A2 mRNA
Genes: SLC38A2; ATA2; KIAA1382; SAT2; SNAT2
Study 37302544 — Predictive Biomarker (PRD): KLF15 mRNA
Genes: KLF15; KKLF
Study 37302573 — Surrogate Endpoint (SUR): Serum creatinine
Study 37303683 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 37303683 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37304043 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37304207 — Predictive Biomarker (PRD): DHH mRNA
Genes: DHH
Study 37304432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 37304494 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37306107 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 37306107 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 37306288 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study 37306717 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 37307001 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 37307844 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37308076 — Surrogate Endpoint (SUR): Blood pressure
Study 37308218 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37308268 — Surrogate Endpoint (SUR): Serum potassium
Study 37308342 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 37308342 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 37308396 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 37308396 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37308396 — Monitoring Biomarker (MOI): Cell-free DNA
Study 37308490 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37308679 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 37308971 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37308971 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37308971 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 37308971 — Predictive Biomarker (PRD): Hormone receptor
Study 37309702 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 37310224 — Predictive Biomarker (PRD): PSIP1 mRNA
Genes: PSIP1; DFS70; LEDGF; PSIP2
Study 37310308 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 37310391 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 37310790 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 37311055 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 37311173 — Surrogate Endpoint (SUR): Blood pressure
Study 37312054 — Surrogate Endpoint (SUR): Pathological complete response
Study 37312118 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 37312118 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 37312251 — Surrogate Endpoint (SUR): Urinary oxalate
Study 37313367 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 37314061 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 37314501 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37314501 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37314501 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 37314501 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 37314797 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 37314797 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 37315114 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37315119 — Surrogate Endpoint (SUR): Blood pressure
Study 37315261 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 37315297 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 37315558 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37315571 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 37315579 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 37315583 — Predictive Biomarker (PRD): SERPINB3 mRNA
Genes: SERPINB3; SCCA; SCCA1
Study 37315879 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 37315924 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 37315924 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 37315924 — Safety Biomarker (SAF): BDNF
Study 37316692 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37316728 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 37317866 — Surrogate Endpoint (SUR): Blood pressure
Study 37317993 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 37318116 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 37318349 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 37318379 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37318580 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 37319354 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 37321244 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 37321625 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 37321625 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 37321663 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 37321665 — Surrogate Endpoint (SUR): Blood pressure
Study 37321955 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37322010 — Predictive Biomarker (PRD): MAOA mRNA
Genes: MAOA
Study 37322010 — Predictive Biomarker (PRD): TPH2 mRNA
Genes: TPH2; NTPH
Study 37322274 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37322367 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37322367 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 37322367 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 37322367 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 37322482 — Predictive Biomarker (PRD): GRN mRNA
Genes: GRN
Study 37322537 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study 37323099 — Surrogate Endpoint (SUR): Bone mineral density
Study 37323099 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 37323869 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 37324125 — Surrogate Endpoint (SUR): Blood pressure
Study 37325351 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study 37325351 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study 37325628 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37325662 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 37325662 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37325662 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 37326562 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 37326645 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37326674 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study 37327461 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study 37328178 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2